• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

19.98 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 19.98
Bid (Size) 19.21 (200)
Ask (Size) 20.06 (200)
Prev. Close 19.98
Today's Range 19.98 - 19.98
52wk Range 5.150 - 25.30
Shares Outstanding 87,012,328
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Announces Pricing of Public Offering of Common Stock
December 16, 2025
From Immunome, Inc.
Via Business Wire

Performance

YTD
-4.0%
-4.0%
1 Month
+1.7%
+1.7%
3 Month
+42.6%
+42.6%
6 Month
+124.7%
+124.7%
1 Year
+85.7%
+85.7%

More News

Read More
News headline image
Why Immunome Stock Surged Today ↗
December 15, 2025
Via The Motley Fool
News headline image
Immunome Announces Proposed Public Offering of Common Stock
December 15, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Where Immunome Stands With Analysts ↗
September 22, 2025
Via Benzinga
News headline image
Where Immunome Stands With Analysts ↗
September 05, 2025
Via Benzinga
News headline image
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From Equity Insider
Via GlobeNewswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
December 15, 2025
Via AB Newswire
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’ ↗
September 05, 2025
Via Stocktwits
News headline image
Which stocks are gapping on Monday? ↗
December 15, 2025
Via Chartmill
News headline image
Why Is IMNM Stock Rising Today? ↗
December 15, 2025
Via Stocktwits
News headline image
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 15, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 14, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at Upcoming Investor Conferences
November 25, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
October 31, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
October 23, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2025
From Immunome, Inc.
Via Business Wire
News headline image
This Crocs Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday ↗
September 22, 2025
Via Benzinga
News headline image
This GATX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
September 22, 2025
Via Benzinga
News headline image
Infinimmune Announces Research Collaboration with Immunome
September 18, 2025
From Infinimmune
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From Immunome, Inc.
Via Business Wire

Frequently Asked Questions

Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 19.98
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 1.74B
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap